News

Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between ...
The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
China said on Wednesday it would further enhance capital market support for science and technology innovation enterprises and ...
The Commission is found to have wrongly refused to publish texts from its president during the Covid pandemic.
Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and ...
A case against one of the major COVID-19 vaccine providers filed by the Kansas Attorney General will be heard at the state ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...